| Tretinoin | Approved Investigational Nutraceutical | DLG3 | 1741 |
upregulated | Tretinoin results in increased expression of DLG3 mRNA | Xq13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DLK1 | 8788 |
downregulated | Tretinoin results in decreased expression of DLK1 mRNA | 14q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DLL1 | 28514 |
downregulated | Tretinoin results in decreased expression of DLL1 mRNA | 6q27 | |
| Tretinoin | Approved Investigational Nutraceutical | DLL3 | 10683 |
downregulated | Tretinoin results in decreased expression of DLL3 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DLX1 | 1745 |
upregulated | Tretinoin results in increased expression of DLX1 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DLX2 | 1746 |
upregulated | Tretinoin results in increased expression of DLX2 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DMD | 1756 |
downregulated | Tretinoin results in decreased expression of DMD mRNA | Xp21.2-p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DMRTC1 | 63947 |
upregulated | Tretinoin results in increased expression of DMRTC1 mRNA | Xq13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DNAJB5 | 25822 |
upregulated | Tretinoin results in increased expression of DNAJB5 mRNA | 9p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DNAJB9 | 4189 |
upregulated | Tretinoin results in increased expression of DNAJB9 mRNA | 7q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DNAJC1 | 64215 |
upregulated | Tretinoin results in increased expression of DNAJC1 mRNA | 10p12.31 | |
| Tretinoin | Approved Investigational Nutraceutical | DNAJC12 | 56521 |
downregulated | Tretinoin results in decreased expression of DNAJC12 mRNA | 10q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DNAJC12 | 56521 |
upregulated | Tretinoin results in increased expression of DNAJC12 mRNA | 10q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DNER | 92737 |
downregulated | Tretinoin results in decreased expression of DNER mRNA | 2q36.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DNM1 | 1759 |
upregulated | Tretinoin results in increased expression of DNM1 mRNA | 9q34.11 | |
| Tretinoin | Approved Investigational Nutraceutical | DNM3 | 26052 |
upregulated | Tretinoin results in increased expression of DNM3 mRNA | 1q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DNM3OS | 100628315 |
upregulated | Tretinoin results in increased expression of DNM3OS mRNA | 1q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DNMT1 | 1786 |
downregulated | Tretinoin results in decreased expression of DNMT1 mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DNMT3A | 1788 |
downregulated | Tretinoin results in decreased expression of DNMT3A mRNA | 2p23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DNMT3B | 1789 |
downregulated | Tretinoin results in decreased expression of DNMT3B mRNA | 20q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | DOCK1 | 1793 |
upregulated | Tretinoin results in increased expression of DOCK1 mRNA | 10q26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DOCK4 | 9732 |
upregulated | Tretinoin results in increased expression of DOCK4 mRNA | 7q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DOCK5 | 80005 |
upregulated | Tretinoin results in increased expression of DOCK5 mRNA | 8p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DOCK8 | 81704 |
upregulated | Tretinoin results in increased expression of DOCK8 mRNA | 9p24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DOCK9 | 23348 |
upregulated | Tretinoin results in increased expression of DOCK9 mRNA | 13q32.3 | |